Delivery Order SPE2DB20D2104-SPE2DB25FMAHJ

Award Date 10/11/24
Potential Completion Date 10/15/24
Potential Value $6.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMAHJ
    Delivery Order

This federal contract award, valued at $6,193.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract involves the delivery of 4,566,088,090 units of cyclosporine 0.05% eye emulsion in 60-count packages. This is a firm fixed-price delivery order contract with an ultimate completion date of October 15, 2024. The contract does not have a set-aside designation. As a significant supplier of pharmaceutical products and medical supplies to the U.S. federal government, AmerisourceBergen has been awarded numerous contracts by various defense and civilian agencies, including the DLA Troop Support Medical, to provide a wide range of essential medications and medical commodities to support military treatment programs, veterans' healthcare, and other federal healthcare initiatives nationwide.

Generated 1/10/25, 9:14 AM